EVE Health Group Limited (AU:EVE) — Market Cap & Net Worth
Market Cap & Net Worth: EVE Health Group Limited (EVE)
EVE Health Group Limited (AU:EVE) has a market capitalization of $4.20 Million (AU$5.94 Million) as of September 24, 2026. Listed on the AU stock exchange, this Australia-based company holds position #29005 globally and #1586 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying EVE Health Group Limited's stock price AU$0.02 by its total outstanding shares 349576592 (349.58 Million). Also see EVE total asset value for a full breakdown of the balance sheet.
EVE Health Group Limited Market Cap History: 2015 to 2026
EVE Health Group Limited's market capitalization history from 2015 to 2026. Data shows growth from $1.09 Million to $4.20 Million (11.64% CAGR). Also see EVE operating cash flow for how efficiently the company converts equity into cash flow.
EVE Health Group Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how EVE Health Group Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check EVE stock price and chart for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
2.99x
EVE Health Group Limited's market cap is 2.99 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.66 Million | $-138.00 | -$1.10 Million | -12008.91x | N/A |
| 2017 | $3.29 Million | $250.00 | -$1.39 Million | 13158.90x | N/A |
| 2018 | $1.24 Million | $18.90K | -$1.88 Million | 65.42x | N/A |
| 2019 | $1.14 Million | $1.60 Million | -$2.64 Million | 0.71x | N/A |
| 2020 | $1.86 Million | $2.31 Million | -$2.40 Million | 0.80x | N/A |
| 2021 | $816.25K | $2.80 Million | -$3.63 Million | 0.29x | N/A |
| 2022 | $494.70K | $2.01 Million | -$5.37 Million | 0.25x | N/A |
| 2023 | $247.35K | $2.33 Million | -$4.04 Million | 0.11x | N/A |
| 2024 | $247.35K | $2.13 Million | -$1.90 Million | 0.12x | N/A |
| 2025 | $5.19 Million | $1.73 Million | -$1.58 Million | 2.99x | N/A |
Competitor Companies of EVE by Market Capitalization
Companies near EVE Health Group Limited in the global market cap rankings as of September 24, 2026. Review tangible equity quality of EVE Health Group Limited to assess the quality of the company's equity after excluding intangible assets.
Key companies related to EVE Health Group Limited by market ranking:
- Nestlé S.A (F:NESM): Ranked #90 globally with a market cap of $224.33 Billion USD ( €191.89 Billion EUR).
- Nestle S.A. (SW:NESN): Ranked #104 globally with a market cap of $199.45 Billion USD ( CHF157.76 Billion CHF).
- Danone SA (PA:BN): Ranked #593 globally with a market cap of $45.85 Billion USD ( €39.22 Billion EUR).
- Danone SA (F:BSND): Ranked #700 globally with a market cap of $39.61 Billion USD ( €33.88 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Nestlé S.A | F:NESM | $224.33 Billion | €81.60 |
| #104 | Nestle S.A. | SW:NESN | $199.45 Billion | CHF77.09 |
| #593 | Danone SA | PA:BN | $45.85 Billion | €60.90 |
| #700 | Danone SA | F:BSND | $39.61 Billion | €11.90 |
EVE Health Group Limited Historical Marketcap From 2015 to 2026
Between 2015 and today, EVE Health Group Limited's market cap moved from $1.09 Million to $ 4.20 Million, with a yearly change of 11.64%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$4.20 Million | -19.05% |
| 2025 | AU$5.19 Million | +2000.00% |
| 2024 | AU$247.35K | 0.00% |
| 2023 | AU$247.35K | -50.00% |
| 2022 | AU$494.70K | -39.39% |
| 2021 | AU$816.25K | -56.00% |
| 2020 | AU$1.86 Million | +63.04% |
| 2019 | AU$1.14 Million | -8.00% |
| 2018 | AU$1.24 Million | -62.41% |
| 2017 | AU$3.29 Million | +98.51% |
| 2016 | AU$1.66 Million | +52.27% |
| 2015 | AU$1.09 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 23rd, 2026 the market cap of EVE Health Group Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.20 Million USD |
| MoneyControl | $4.20 Million USD |
| MarketWatch | $4.20 Million USD |
| marketcap.company | $4.20 Million USD |
| Reuters | $4.20 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About EVE Health Group Limited
EVE Health Group Limited, together with its subsidiaries, engages in the development, retail, and commercialization of health and wellness, and pharmaceutical products. The company lead product is Dyspro, a proprietary pharmaceutical-grade formulation to address dysmenorrhea (menstrual pain); and Libbo, a proprietary pharmaceutical-grade oral dissolving film formulation for the treatment of erect… Read more